FDAsafety guidance84% confidence
Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Medline; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Medline is correcting affected convenience kits by removing recalled Bupivacaine Hydrochloride in Dextrose Injection components.
Supporting Context
- Therapeutic area
- Infection Control · Medical Devices
- Sub-indication
- General
Related signal: FDA Alerts on Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits